Literature DB >> 25246354

Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.

Sita Jayalakshmi1, Devashish Ruikar2, Sudhindra Vooturi2, Suvarna Alladi3, Sambit Sahu4, Subhash Kaul3, Surath Mohandas2.   

Abstract

IMPORTANCE: Super refractory status epilepticus (SRSE) is a recent entity. There is limited information about the etiology and outcome of SRSE from developing countries.
OBJECTIVE: We evaluated determinants and predictors of outcome in patients with convulsive SRSE in Indian population.
METHODS: In this open cohort study, data of patients with convulsive SE admitted in neurointensive care unit (NICU) from 2005 to 2013 was retrospectively analyzed. Regression and survival analysis was done for outcome of patients divided into non refractory SE (NRSE), refractory SE (RSE), and SRSE groups. MAIN OUTCOME MEASURE: The primary outcome for analysis was in hospital mortality. Also functional outcome at 6 months was graded according to the Glasgow outcome scale (GOS), and classified as good (GOS 4 and 5) and poor (GOS 1, 2 and 3) outcome groups.
RESULTS: Out of 177 patients with SE, 105 (59.3%) had NRSE; 72 (40.7%) had RSE of which 30 (16.9% of 177) were sub-classified as SRSE. SRSE was frequent (39%) in children (p<0.01), elderly (21.7%; p<0.003), and in incident SE (82.1%, p=0.05). Encephalitis was the commonest etiology in RSE (30.9%, p=0.015), SRSE (66.7%, p<0.001) than NRSE (12.3%). Encephalitis (β=8.250 (1.8-37.82); p=0.007) was the determinant of the progression of SE to SRSE. Overall mortality was 19.2%, highest in SRSE (40.0%) followed by RSE (35.7%), both significantly (p<0.001) higher than NRSE (6.7%). Mortality was high in patients with encephalitis than other etiologies (39.1% vs. 12.1%; p=0.001). Acidosis predicted mortality in the entire cohort (β=7.313 (1.6-32.58); p=0.009); however none of the variables predicted mortality in SRSE patients. At 6 months follow up only 33.3% of patients with SRSE were in GOS good outcome group when compared to RSE (33.3% vs. 57.1%; p=0.055), and NRSE (33.3% vs. 79.1%; p<0.0001). CONCLUSIONS AND RELEVANCE: SRSE is common in children, elderly, and incident SE. Encephalitis was the determinant of progression of SE to SRSE. None of the variables predicted mortality in SRSE patients. Sixty percent of patients with SRSE survived and one third had good outcome. Therefore one should continue the care inspite of weeks of SE.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acidosis; Encephalitis; Mortality; Status epilepticus; Super refractory status epilepticus

Mesh:

Substances:

Year:  2014        PMID: 25246354     DOI: 10.1016/j.eplepsyres.2014.08.010

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

Review 1.  [Management of refractory and super-refractory status epilepticus].

Authors:  Frank Erbguth
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-28       Impact factor: 0.840

Review 2.  Super-Refractory Status Epilepticus.

Authors:  Mauricio Ruiz Cuero; Panayiotis N Varelas
Journal:  Curr Neurol Neurosci Rep       Date:  2015-11       Impact factor: 5.081

3.  Utility of the END-IT Score to Predict the outcome of Childhood Status Epilepticus: A Retrospective Cohort Study.

Authors:  Dipti Kapoor; Divyani Garg; Rajiv K Malhotra; Virendra Kumar; Suvasini Sharma
Journal:  Ann Indian Acad Neurol       Date:  2021-06-29       Impact factor: 1.383

4.  Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score.

Authors:  Qiong Gao; Tang-peng Ou-Yang; Xiao-long Sun; Feng Yang; Chen Wu; Tao Kang; Xiao-gang Kang; Wen Jiang
Journal:  Crit Care       Date:  2016-02-25       Impact factor: 9.097

Review 5.  Legal challenges in neurological practice.

Authors:  Sita Jayalakshmi; Sudhindra Vooturi
Journal:  Ann Indian Acad Neurol       Date:  2016-10       Impact factor: 1.383

6.  A Study of Super Refractory Status Epilepticus from India.

Authors:  Usha K Misra; Jayantee Kalita; Deepanshu Dubey
Journal:  Front Neurol       Date:  2017-11-28       Impact factor: 4.003

7.  Ketogenic Diet in the Treatment of Super-Refractory Status Epilepticus at a Pediatric Intensive Care Unit: A Single-Center Experience.

Authors:  Markus Breu; Chiara Häfele; Sarah Glatter; Petra Trimmel-Schwahofer; Johann Golej; Christoph Male; Martha Feucht; Anastasia Dressler
Journal:  Front Neurol       Date:  2021-06-03       Impact factor: 4.003

Review 8.  Markers in Status Epilepticus Prognosis.

Authors:  Ayham Alkhachroum; Caroline A Der-Nigoghossian; Clio Rubinos; Jan Claassen
Journal:  J Clin Neurophysiol       Date:  2020-09       Impact factor: 2.590

9.  Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany.

Authors:  Lena-Marie Kortland; Susanne Knake; Felix von Podewils; Felix Rosenow; Adam Strzelczyk
Journal:  Front Neurol       Date:  2017-09-26       Impact factor: 4.003

10.  A Comparative Study of Midazolam and Target-Controlled Propofol Infusion in the Treatment of Refractory Status Epilepticus.

Authors:  Dheeraj Masapu; K N Gopala Krishna; Sinha Sanjib; Dhrithiman Chakrabarti; R C Mundlamuri; Nitin Manohar; P Mariamma; P Satishchandra; G S Umamaheswara Rao
Journal:  Indian J Crit Care Med       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.